Literature DB >> 10771485

Competition analysis of the human alpha2(I) collagen promoter using synthetic oligonucleotides.

H Ihn1, K Tamaki.   

Abstract

Previous studies have identified four cis-response elements which mediate the basal transcriptional activity of the human alpha2(I) collagen gene. One of these elements, a pyrimidine-rich region (TCCCCC motif), was shown to be a repressor site, and the other three elements were shown to be activator sites. Furthermore, the repressor site and two of the activator sites were found to constitute binding sites for the transcription factors Sp1 and Sp3. In this study, we further determined the affinity and specificity of the binding of Sp1 and Sp3 to the human alpha2(I) collagen promoter and investigated the function of the pyrimidine-rich region which contains the TCCCCC motif. Functional analyses of Sp1 and Sp3 in Drosophila cells confirmed that Sp1 and Sp3 activate the human alpha2(I) collagen promoter via the GC boxes and the TCCTCC motif, but that binding of Sp1 or Sp3 to the repressor site does not activate or repress the collagen promoter activity. Com- petitive analyses using DNA mobility shift assays showed that the TCCCCC motif which constitutes the repressor site abolished the binding of Sp1 or Sp3 to the GC boxes or the TCCTCC motif, but not the binding of CCAAT-binding factor to the fourth cis-response element (CCAAT-binding factor site). Furthermore, the affinity of Sp1 or Sp3 for the TCCTCC motif was shown to be greater than that of the Sp1 consensus oligonucleotide. In vitro transcription analysis revealed that the addition of each activator site oligonucleotide or repressor site oligonucleotide had an inhibitory effect on the transcription of the collagen gene. These results suggest that the repressor site regulates the transcription of the collagen gene by taking away Sp1 or Sp3 from the activator sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771485     DOI: 10.1046/j.1523-1747.2000.00956.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.

Authors:  Hironobu Ihn
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

2.  Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.

Authors:  Kaname Akamata; Yoshihide Asano; Takashi Yamashita; Shinji Noda; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Maria Trojanowska; Shinichi Sato
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

3.  Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.

Authors:  Rui Li; Jie Xiao; Xiaoteng Qing; Junhui Xing; Yanfei Xia; Jia Qi; Xiaojun Liu; Sen Zhang; Xi Sheng; Xinyu Zhang; Xiaoping Ji
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

4.  miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1.

Authors:  Rui Li; Hai-Hua Geng; Jie Xiao; Xiao-Teng Qin; Fu Wang; Jun-Hui Xing; Yan-Fei Xia; Yang Mao; Jing-Wen Liang; Xiao-Ping Ji
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

5.  MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1.

Authors:  Vivek P Singh; Megumi Mathison; Vivekkumar Patel; Deepthi Sanagasetti; Brian W Gibson; Jianchang Yang; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2016-11-10       Impact factor: 5.501

6.  Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts.

Authors:  Masatoshi Jinnin; Hironobu Ihn; Kenichi Yamane; Yoshihiro Mimura; Yoshihide Asano; Kunihiko Tamaki
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

7.  Chondroitin sulphate decreases collagen synthesis in normal and scleroderma fibroblasts through a Smad-independent TGF-beta pathway--implication of C-Krox and Sp1.

Authors:  Emmanuelle Renard; Christos Chadjichristos; Magdalini Kypriotou; Gallic Beauchef; Pascal Bordat; Anne Dompmartin; Russell L Widom; Karim Boumediene; Jean-Pierre Pujol; Philippe Galéra
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

8.  Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.

Authors:  Kaname Akamata; Yoshihide Asano; Naohiko Aozasa; Shinji Noda; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Shinichi Sato
Journal:  Arthritis Res Ther       Date:  2014-04-03       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.